Market Overview:
The global hemoglobin A1c testing devices for diabetes market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing prevalence of diabetes, technological advancements in hemoglobin A1c testing devices, and rising demand for point-of-care testing devices. Based on type, the global hemoglobin A1c testing devices for diabetes market can be segmented into boronate affinity chromatography, direct enzymatic assay, immunoassay, ion-exchange HPLC, micro-optical detection method and capillary electrophoresis. Based on application, the market can be divided into laboratory testing devices and point-of-care testing devices. Geographically speaking, North America is expected to lead the global hemoglobin A1ctestingdevices for diabetesmarket duringthe forecastperiod owingto therelatively highprevalence ofdiabetes in this region as well asthe presence ofmajor players operating in thismarket. However,.
Product Definition:
Hemoglobin A1c (A1C) is a blood test that measures the percentage of hemoglobin in your blood that is glycated. Hemoglobin is a protein in red blood cells that carries oxygen from your lungs to the rest of your body. When glucose levels are high, more sugar binds to hemoglobin. The higher the A1C level, the greater the amount of time your blood sugar has been high.
Boronate Affinity Chromatography:
Boronate affinity chromatography is a technique used for the purification of proteins and other biomolecules. It involves an interaction between protein or other compound of interest and borosilicate resin, which in turn, makes the process easier by increasing the binding strength between resin and target molecule.
Direct Enzymatic Assay:
Direct enzymatic assay (DAA) is a method used for measuring the level of hemoglobin A1c (A1C) in human plasma or serum. It is considered as one of the most accurate and sensitive methods for monitoring blood glucose levels. The major advantage associated with this method includes its ability to measure A1C even in the presence of a small amount of glucose and other proteins, which are normally present in high concentrations.
Application Insights:
Laboratory testing devices held the largest market share in 2017. This is due to the wide application of these devices for the detection and monitoring of diabetes-related complications. These include diabetic retinopathy, kidney failure, neuropathy, and cardiovascular disease. The increasing prevalence of diabetes is anticipated to boost product demand over the forecast period.
Point-of-care testing devices are expected to register a significant CAGR during the forecast period owing to their ability to detect hemoglobin A1c levels at point of care without any laboratory processing or equipment needed other than an instrumentation with a reader device that can be used by patients themselves at home or places where they cannot go for medical checkups such as hospitals and clinics.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of diabetes and other cardiovascular diseases (CVDs). According to data published by CDC, around 29.1 million people were diagnosed with diabetes in 2015. Moreover, technological advancements such as miniaturization and automation of laboratory instruments are also expected to drive regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period due to rising disposable income levels and improving healthcare infrastructure in emerging countries such as India, China, Singapore & Malaysia. Furthermore, increasing awareness about hemoglobin A1c testing devices for diabetes management is anticipated favorably impact regional demand during the forecast period.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. According to the World Health Organization (WHO), the number of people with diabetes has quadrupled since 1980 and as of 2014, there were 422 million people living with diabetes worldwide. This number is expected to reach 642 million by 2040. This growing population will create a greater demand for hemoglobin A1c testing devices for diagnosing and managing diabetes.
- Advances in technology: Hemoglobin A1c testing devices are becoming increasingly sophisticated, thanks to advances in technology. These devices can now provide more accurate results in a shorter time frame, making them an attractive option for clinicians and patients alike. As technology continues to evolve, hemoglobin A1c testing devices are likely to become even more advanced and popularized within the medical community.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemoglobin A1c Testing Devices for Diabetes Market Research Report
By Type
Boronate Affinity Chromatography, Direct Enzymatic Assay, Immunoassay, Ion-Exchange HPLC, Micro-Optical Detection Method, Capillary Electrophoresis
By Application
Laboratory Testing Devices, Point-of-Care Testing Devices
By Companies
Abbott, ARKRAY, Bio-Rad, PTS Diagnostics, Beckman Coulter, EKF Diagnostics, Roche, Menarini Group, Sebia, Siemens Healthcare, Tosoh, Trinity Biotech, Danaher Corporation, A. Menarini Diagnostics, HUMAN Diagnostics, OSANG Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Hemoglobin A1c Testing Devices for Diabetes Market Report Segments:
The global Hemoglobin A1c Testing Devices for Diabetes market is segmented on the basis of:
Types
Boronate Affinity Chromatography, Direct Enzymatic Assay, Immunoassay, Ion-Exchange HPLC, Micro-Optical Detection Method, Capillary Electrophoresis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory Testing Devices, Point-of-Care Testing Devices
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- ARKRAY
- Bio-Rad
- PTS Diagnostics
- Beckman Coulter
- EKF Diagnostics
- Roche
- Menarini Group
- Sebia
- Siemens Healthcare
- Tosoh
- Trinity Biotech
- Danaher Corporation
- A. Menarini Diagnostics
- HUMAN Diagnostics
- OSANG Healthcare
Highlights of The Hemoglobin A1c Testing Devices for Diabetes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Boronate Affinity Chromatography
- Direct Enzymatic Assay
- Immunoassay
- Ion-Exchange HPLC
- Micro-Optical Detection Method
- Capillary Electrophoresis
- By Application:
- Laboratory Testing Devices
- Point-of-Care Testing Devices
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemoglobin A1c Testing Devices for Diabetes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A1c testing devices are used to measure the average blood sugar level over a period of time. Hemoglobin A1c is a protein that helps to control blood sugar levels.
Some of the major players in the hemoglobin a1c testing devices for diabetes market are Abbott, ARKRAY, Bio-Rad, PTS Diagnostics, Beckman Coulter, EKF Diagnostics, Roche, Menarini Group, Sebia, Siemens Healthcare, Tosoh, Trinity Biotech, Danaher Corporation, A. Menarini Diagnostics, HUMAN Diagnostics, OSANG Healthcare.
The hemoglobin a1c testing devices for diabetes market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hemoglobin A1c Testing Devices for Diabetes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hemoglobin A1c Testing Devices for Diabetes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hemoglobin A1c Testing Devices for Diabetes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hemoglobin A1c Testing Devices for Diabetes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hemoglobin A1c Testing Devices for Diabetes Market Size & Forecast, 2018-2028
4.5.1 Hemoglobin A1c Testing Devices for Diabetes Market Size and Y-o-Y Growth
4.5.2 Hemoglobin A1c Testing Devices for Diabetes Market Absolute $ Opportunity
Chapter 5 Global Hemoglobin A1c Testing Devices for Diabetes Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Type
5.2.1 Boronate Affinity Chromatography
5.2.2 Direct Enzymatic Assay
5.2.3 Immunoassay
5.2.4 Ion-Exchange HPLC
5.2.5 Micro-Optical Detection Method
5.2.6 Capillary Electrophoresis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hemoglobin A1c Testing Devices for Diabetes Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Applications
6.2.1 Laboratory Testing Devices
6.2.2 Point-of-Care Testing Devices
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hemoglobin A1c Testing Devices for Diabetes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hemoglobin A1c Testing Devices for Diabetes Analysis and Forecast
9.1 Introduction
9.2 North America Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Type
9.6.1 Boronate Affinity Chromatography
9.6.2 Direct Enzymatic Assay
9.6.3 Immunoassay
9.6.4 Ion-Exchange HPLC
9.6.5 Micro-Optical Detection Method
9.6.6 Capillary Electrophoresis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Applications
9.10.1 Laboratory Testing Devices
9.10.2 Point-of-Care Testing Devices
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hemoglobin A1c Testing Devices for Diabetes Analysis and Forecast
10.1 Introduction
10.2 Europe Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Type
10.6.1 Boronate Affinity Chromatography
10.6.2 Direct Enzymatic Assay
10.6.3 Immunoassay
10.6.4 Ion-Exchange HPLC
10.6.5 Micro-Optical Detection Method
10.6.6 Capillary Electrophoresis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Applications
10.10.1 Laboratory Testing Devices
10.10.2 Point-of-Care Testing Devices
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hemoglobin A1c Testing Devices for Diabetes Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Type
11.6.1 Boronate Affinity Chromatography
11.6.2 Direct Enzymatic Assay
11.6.3 Immunoassay
11.6.4 Ion-Exchange HPLC
11.6.5 Micro-Optical Detection Method
11.6.6 Capillary Electrophoresis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Applications
11.10.1 Laboratory Testing Devices
11.10.2 Point-of-Care Testing Devices
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hemoglobin A1c Testing Devices for Diabetes Analysis and Forecast
12.1 Introduction
12.2 Latin America Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Type
12.6.1 Boronate Affinity Chromatography
12.6.2 Direct Enzymatic Assay
12.6.3 Immunoassay
12.6.4 Ion-Exchange HPLC
12.6.5 Micro-Optical Detection Method
12.6.6 Capillary Electrophoresis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Applications
12.10.1 Laboratory Testing Devices
12.10.2 Point-of-Care Testing Devices
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hemoglobin A1c Testing Devices for Diabetes Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Type
13.6.1 Boronate Affinity Chromatography
13.6.2 Direct Enzymatic Assay
13.6.3 Immunoassay
13.6.4 Ion-Exchange HPLC
13.6.5 Micro-Optical Detection Method
13.6.6 Capillary Electrophoresis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hemoglobin A1c Testing Devices for Diabetes Market Size Forecast by Applications
13.10.1 Laboratory Testing Devices
13.10.2 Point-of-Care Testing Devices
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hemoglobin A1c Testing Devices for Diabetes Market: Competitive Dashboard
14.2 Global Hemoglobin A1c Testing Devices for Diabetes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 ARKRAY
14.3.3 Bio-Rad
14.3.4 PTS Diagnostics
14.3.5 Beckman Coulter
14.3.6 EKF Diagnostics
14.3.7 Roche
14.3.8 Menarini Group
14.3.9 Sebia
14.3.10 Siemens Healthcare
14.3.11 Tosoh
14.3.12 Trinity Biotech
14.3.13 Danaher Corporation
14.3.14 A. Menarini Diagnostics
14.3.15 HUMAN Diagnostics
14.3.16 OSANG Healthcare
